Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Dec 20;15(1):3. doi: 10.3390/pharmaceutics15010003

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

In vitro aerosol performance of M33_PEG 2000-Rhod and M33_PEG 5000-Rhod delivered through Aeroneb^® Go and PARI TurboBOY nebulizers: Cumulative mass recovered was a function of the cut-off diameter of the NGI stages (A,B), NGI deposition pattern (A’,B’). The emitted dose was measured as the difference between the total amount of NPs initially placed in the nebulizer chamber and the amount remaining. At the flow rate used (15 L/min), the cut-off diameters of the NGI stages were 0.98 µm (Cup 1), 1.36 µm (Cup 2), 2.08 µm (Cup 3), 3.3 µm (Cup 4), 5.39 µm (Cup 5), 8.61 µm (Cup 6), 14.1 µm (Cup 7). No significant differences were observed for all the formulations tested (one-way ANOVA multiple comparison; p > 0.05).